Resource Summary Report  New Search Previous Search Results

URL: https://dx.doi.org/DOI:10.17504/protocols.io.mcqc2vw

Authors: Cibrián Angelica, Sánchez Miguel, García Sara, Pérez Eduardo, Bernal German, Castañon Migel, Jiménez Laura, Toledano Cairo

Summary: The third report of the National Cholesterol Education Program guidelines recommend calculating the 10-year morbidity of atherosclerotic cardiovascular disease using risk calculators when treating high blood cholesterol in adults. We analyzed the changes in cardiovascular risk (CVR) among patients with human immunodeficiency virus (HIV) from México.Materials and MethodsThis observational, prospective cohort study compared the cardiovascular risk after one year of usual treatment among 460 HIV patients in México. Changes using the atherosclerotic cardiovascular disease risk estimator and changes in clinical outcomes were analyzed. The results were categorized as low or high CVR using a cut-off of 7.5%.The cardiovascular risk at baseline showed a mean of 4.45% ± 6.1% (0.2% to 50.1%), which changed to 4.48% ± 5.4% (0.2% to 33.2one year later . After cardiovascular risk stratification at baseline, we found that 84.3% of patients had a low CVR, and 18% of this group had metabolic syndrome. Moreover, 15.7% of this population was at high cardiovascular risk and 47% had metabolic syndrome. Approximately 4.3% of patients had a CVR increase and 2.6% had a cardiovascular risk decrease. Of the total patients, 22.3% had metabolic syndrome at baseline.

Affiliations: Faculty of Pharmacy, University of Morelos, Center for Infectious Diseases Research, National Institute of Public Health,, Faculty of Pharmacy, University of Morelos, Mexican Institute of Social Security Morelos, México., Faculty of Pharmacy, University of Morelos, Mexican Institute of Social Security Morelos, México., Mexican Institute of Social Security Morelos, México., Faculty of Pharmacy, University of Morelos

Version: 1

Publication Date: 2017

Expand All Collapse